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Abstract
Background: The ErbB3 binding protein-1 (Ebp1) belongs to a family of DNA/RNA binding
proteins implicated in cell growth, apoptosis and differentiation. However, the physiological role of
Ebp1 in the whole organism is not known. Therefore, we generated Ebp1-deficient mice carrying a
gene trap insertion in intron 2 of the Ebp1 (pa2g4) gene.
Results: Ebp1-/- mice were on average 30% smaller than wild type and heterozygous sex matched
littermates. Growth retardation was apparent from Day 10 until Day 30. IGF-1 production and
IGBP-3 and 4 protein levels were reduced in both embryo fibroblasts and adult knock-out mice.
The proliferation of fibroblasts derived from Day 12.5 knock out embryos was also decreased as
compared to that of wild type cells. Microarray expression analysis revealed changes in genes
important in cell growth including members of the MAPK signal transduction pathway. In addition,
the expression or activation of proliferation related genes such as AKT and the androgen receptor,
previously demonstrated to be affected by Ebp1 expression in vitro, was altered in adult tissues.
Conclusion: These results indicate that Ebp1 can affect growth in an animal model, but that the
expression of proliferation related genes is cell and context specific. The Ebp1-/- mouse line
represents a new in vivo model to investigate Ebp1 function in the whole organism.
Background
Members of the ErbB receptor tyrosine kinase family
(ErbB1-4) and their ligands are important regulators of
cell growth and differentiation. Studies of ErbB1, ErbB2
and heregulin (the ErbB3/4 ligand) deficient mice indi-
cate that these genes are essential for embryonic develop-
ment [1]. In turn, the activity of the ErbB receptors is
regulated by their interacting partners. An ErbB3 binding
protein (Ebp1) was cloned in our laboratory during a
yeast two-hybrid screen [2]. Ebp1 is identical to the
murine p38-2G4 protein which was isolated as a DNA
binding protein[3]. These proteins are members of the
Proliferation-associated 2G4 (Pa2g4) gene family, which
is highly conserved throughout evolution [4]. More than
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30 genes encoding proteins homologous to Ebp1 have
been found in organisms ranging from Danio rerio to Pan
troglodytes [5].
Ebp1 is expressed in mammalian cell lines derived from
multiple origins. Ebp1 mRNA is also found in all normal
adult human and murine tissues examined including
liver, heart, brain, placenta, lung, muscle, pancreas, kid-
ney, prostate and breast [6,7]. Examination of EST data
bases reveals that Ebp1 is expressed in all tissue types at
different stages of embryonic development. Its ubiquitous
distribution in both embryonic and adult tissues suggests
it affects various developmental and physiological path-
ways [6].
An important role for Ebp1 in cell proliferation and sur-
vival in vitro has been demonstrated by many groups. We
have shown that Ebp1 inhibits transcription of E2F1 reg-
ulated cell cycle genes such as E2F1, Cyclin D1 and cyclin
E [8]. This transcriptional regulation is due in part to inter-
actions with the transcriptional corepressors Sin3A, Rb
and HDAC2 on E2F1 regulated promoters [9,10]. Ectopic
expression of Ebp1  inhibits the growth of human
breast[11] and prostate cancer cells [9,12] and fibroblasts
[13] both in vitro and in animal models [14]. In breast
cancer cell lines, Ebp1 regulates levels of ErbB2 and con-
trols the cellular response to heregulin and the antiestro-
gen tamoxifen [15]. In prostate cancer, ectopic expression
of Ebp1 results in downregulation of Androgen Receptor
(AR) and several of its target genes and inhibition of AR-
regulated cell growth [14]. Ebp1 also has a role in regulat-
ing cell survival as its interaction with AKT kinase sup-
presses apoptosis[16].
The mechanisms by which Ebp1 exerts its effects on cell
proliferation and survival are incompletely understood.
The biological effects of Ebp1 were originally postulated
to be based on its ability to bind DNA. Ebp1 is a member
of the SF00553 protein superfamily, the prototype of
which is a 42 KDa DNA binding protein isolated from the
fission yeast S. pombe [17]. Blast analysis reveals that Ebp1
and the yeast 42 KDa protein have 38% amino acid iden-
tity and 56% similarity. The S. pombe protein preferen-
tially binds a synthetic curved DNA sequence. Ebp1 binds
directly to this synthetic curved DNA sequence and is
recruited to E2F1 promoter elements in vitro and in vivo as
part of a protein complex [18]. The interaction of Ebp1
with the E2F1 promoter is regulated by the ErbB3 ligand
HRG.
In addition to its ability to interact with proteins and
DNA, Ebp1 binds to an array of RNA targets. Squaritto et
al [13] found that a pool of EBP1 localized to the nucleo-
lus binds RNA and may be involved in ribosomal biogen-
esis. EBP1 can bind to B23 (nucleophosmin), as a
component of pre- ribosomal ribonucleoprotein com-
plexes [19]. In the cytoplasm, Ebp1 associates with the 40
S subunit of mature ribosomes, suggesting that it can also
be involved in protein translation. Sedimentation studies
revealed that Ebp1 copurified with eIF2α, a component of
the translation initiation complex [20]. Ebp1 contains an
RNA binding domain σ- 70 like motif that maps to aa 46–
64 that mediates its interaction with RNA and its nucleo-
lar localization [13]. A double-stranded RNA binding
domain was also mapped to aa 91–156. Other studies
showing that EBP1 binds the 3'UTR of bcl-2 mRNA and
stabilizes β-globin-ARE bcl-2 transcripts [21] suggest that
EBP1 is a functional RNA binding protein. Finally, Ebp1
has been demonstrated to bind to viral internal ribosome
entry sites (IRES) [22].
Despite burgeoning interest in the role of Ebp1 in several
important cellular activities, the physiological function of
Ebp1 in the intact organism is not known. We therefore
characterized Ebp1- deficient mice generated by a gene
trap insertion in intron 2 of the pa2g4 gene. We show that
Ebp1-deficient mice exhibit transient dwarfism. This is
accompanied by a decrease in serum levels of IGF-1 and
IGF binding proteins and changes in expression of several
other genes associated with cell growth. These results pro-
vide in vivo evidence that Ebp1 plays an important role in
cellular growth.
Results
Disruption of the Ebp1 gene
Ebp1+/- mice were generated at Lexicon Genetics from ES
cells containing a retroviral gene trap in the Ebp1 locus as
described previously [23]. Sequence analysis showed that
the gene trap was inserted at a single site in the 2.3 kb
intron 2 of the Ebp1 gene (Fig. 1A, B). The insertion led to
the expression of an Ebp1-neomycin fusion molecule
containing only the first 20 amino acids that are encoded
by Exon 1 of Ebp1 that has no known biological function.
The mice were genotyped by PCR with primers located at
each side of the gene trap and in the LTR2 cassette (Fig.
1C).
The absence of Ebp1 mRNA in Ebp1-/- mice was confirmed
by RT-PCR with β actin as an internal control on total
mRNA from 12.5 day embryo fibroblasts. The transcript
was present in fibroblasts from wild type, but not Ebp1-/-
MEF (Fig. 2A). In addition, Western blot analysis indi-
cated that Ebp1 protein was not expressed in knock out
MEFs (Fig. 2B).
Ebp1 expression in adult life
Examination of EST data bases and our own published
data [6] indicate that Ebp1 is ubiquitously expressed in
normal adult mouse tissue. We therefore measured Ebp1
protein expression in several organs to determine the pen-BMC Cell Biology 2008, 9:69 http://www.biomedcentral.com/1471-2121/9/69
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etrance of the knock out. We found as expected that Ebp1
was expressed in adult lung and kidney of 10 week old
wild type mice. Ebp1 expression was absent in the Ebp1-/
- mouse (Fig. 2C).
Breeding data and post natal lethality
Breeding data were obtained from crosses between both
heterozygous and homozygous mice, since both Ebp1+/-
and Ebp1-/-male and females were fertile. In all cases, the
sex ratio was approximately 1:1. The genotypes of the
pups from heterozygous pairs were present at approxi-
mately the expected ratio of 25:50:25 (Ebp1+/+, Ebp1+/-
and Ebp1-/-) (n = 40). Survival was approximately equal
for all three groups eight weeks after birth. Male and
female knock-out mice were fertile and inbred mating
resulted in viable offspring. However, litter size was
smaller for the Ebp1-/- mice. Litter size of wild type mice
was 9.1 ± .8, and for knock out mice,4.2 ± 1.3 (4 litters for
each group).
In general, life expectancy, of knock out mice was indistin-
guishable compared with their littermates. Ten mice of
each genotype were maintained for one year. 9/10 knock
out and 10/10 heterozygous and 10/10 wild type mice
survived.
Reduced growth of Ebp1-/- mice
The most striking feature of adult Ebp1-/- mice is their ini-
tial smaller body size (Fig. 3A) and in about 1/3 of the
mice the presence of kinky tails. The progeny of crosses
between heterozygous parents were kept with the hetero-
zygous mother and weighed sequentially. At day 19, there
was a significant (p = .008) reduction of approximately
30% in body weight for both males and females. Mice
were weaned at Day 21. After Day 30 mice began to catch
Generation of the Ebp1 null mouse Figure 1
Generation of the Ebp1 null mouse. A. Schematic representation of the retroviral integration site within the first intron of 
the mouse pa2g4 (Ebp1) gene in the ES clone OST 186047 is indicated. Exons are represented as boxes. B. The locations of the 
PCR primers (LTR2, Ebp1 R, Ebp1 F) used in genotyping are indicated. Their positions (in base pairs) relative to the sites of 
integration are shown (not drawn to scale). LTR = long terminal repeat; SA and SD = splice acceptor and splice donor sites, 
respectively; PGK = phosphoglycerate kinase 1. C. A typical genotyping analysis showing the 308 bp PCR fragment for a wild 
type allele and the 253 bp product that detects the viral integration site. The products were separated by agarose gel electro-
phoresis and visualized by ethidium bromide staining.
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up in size with wild type litter mates and at Day 60 there
were no differences in weight (Fig. 3B). To rule out the
possibility that competition during milk sucking was
responsible for growth retardation, Ebp1-/-  males and
females or wild type males and females were crossed. KO
or WT progeny were housed alone with their mother.
Males and females were weighed and data pooled due to
difficulties in determining sex at early time points.
Weights were the same for WT and KO mice at Day 4.
However, at Days 10 and 18, these mice also displayed a
25% reduction in weight (2 litters, 9 total knock out, 15
total wild type).
Macro and microscopic appearance of organs
To identify development defects and or pathological fea-
tures, we examined the macro and microscopic appear-
ance of a series of organs from adult Ebp1 mice. There
were no gross morphological differences between the
Ebp1+/+ and Ebp1-/- mice at 10 weeks of age. The examina-
tion of hematoxylin and eosin stained sections from
organs revealed no histological changes in gut, kidney,
lymph nodes, testes, liver, spleen, pancreas, skeletal mus-
cle, lung, testis and ovaries. Peripheral blood counts and
blood chemistries (including glucose, Bun, ALT, and Total
Protein) were within normal limits. Glucose levels were
245 ± 24 mg/dl for knock-out mice and 233 ± 50 mg/dl
for wild type mice.
Proliferative behavior of MEFS
As Ebp1-/- mice were small and the Ebp1(pa2g4) gene was
originally identified as a proliferation associated gene, we
examined the proliferative behavior of 12.5 day mouse
embryo fibroblasts. Under the standard culture condi-
tions used, the number of MEFs from Ebp1-/- mice was
lower at all the time points tested (Fig. 4A). In addition,
we were able to propagate wild type MEFs for 5 passages,
but Ebp1-/- MEFs for only 3. A senescent morphology was
observed at passage 3 for knock out MEFs (Fig. 4B).
Target gene and global expression profiling in MEFs
To obtain additional information about the cellular path-
ways involved in the phenotype of the MEFs, we per-
formed global expression profiling of matched 12.5 day
MEFs. The expression data have been deposited with the
GEO data base http://www.ncbi.nlm.nih.gov/projects/
geo/ as GSE13718. A total of 99 genes were changed more
than two fold (500 expression units minimum). Among
the transcripts involved in growth regulation, we found
that several members of the insulin, EGFR, Cyclin and
MAPK families were significantly changed (Table 1). To
verify these findings, we first examined the expression of
Cyclin D1 which has previously been shown to be
repressed by ectopic expression of Ebp1 in human breast
cancer cell lines [24,8]. We found by RT-PCR and quanti-
tative PCR analysis that Cyclin D1 mRNA was increased
(Fig. 5A, B). However, Cyclin D1 protein levels were equal
in wild type and knock out MEFs reflecting the complex
regulation of Cyclin D1 protein expression [25] (Fig. 5C).
Three regulators of the insulin signaling pathway were
also found to be significantly decreased. These include
IGF-1, IGFBP-3 and IGFBP-4. The levels of IGF-1 were
measured by ELISA in conditioned media derived from
wild type and knock out MEFs. The concentration of IGF-
1 in conditioned media from 3 day cultures of MEFs was
305 ± 25 pg/ml for knock out cells and 480 ± 32 pg/ml for
wild type MEFs.
Alterations of EGF-regulated signaling pathways
Our microarray data indicated that two members of the
MAPK signal transduction pathway, SOS1 and Grb14
Ebp1 is not expressed in Ebp1-/- animals Figure 2
Ebp1 is not expressed in Ebp1-/- animals. A, B. Fibrob-
lasts were derived from 12.5 day Ebp1-/- (KO) and wild type 
(WT) embryos as described in the Materials and Methods. A. 
RNA was isolated and the expression of Ebp1 and actin was 
determined by conventional PCR analysis. B. The expression 
of Ebp1 in KO and WT MEFs was analyzed by Western blot 
analysis. C. The expression of Ebp1 from lung (L) and kidneys 
(K) of 10 week old Ebp1-/- and wild type littermates was 
detected by Western blot analysis.
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were upregulated in knock-out as compared with wild
type MEFs. We verified by Western blot analysis that SOS
was increased in Ebp1 knock out MEFs as compared with
wild type cells (Fig. 6A). We therefore tested if the cellular
response to EGF would be changed in Ebp1 knock out
MEFs. Murine MEFs are known to express EGFR and EGFR
mRNA expression was not changed in Ebp1 knock outs
(data not shown)[26]. Cells were treated with EGF (20 ng/
ml) for the times indicated and MAPK activation assessed
by detection of phosphorylated MAPK by Western blot
analysis. The results indicated that both wild type and
knock out MEFs could respond to EGF stimulation as evi-
denced by phosphorylation of MAPK. However, MAPK
was basally phosphorylated only in knock out MEFS (Fig.
6B). EGF-induced AKT phosphorylation in wild type and
knock out cells was also determined using a phospho spe-
cific AKT antibody. The response to EGF was equivalent in
wild type and knock out cells (Fig. 6C).
Changes in expression of proliferation associated genes in 
adult target tissues
Previous in vitro work with Ebp1 has used breast and pros-
tate cancer cell lines derived from adults. In these tissues,
the expression of Cyclin D1[24], AGR2 [27] and androgen
receptor [14] have been shown to be regulated by Ebp1.
We therefore examined expression of these genes in adult
mammary and prostate epithelium. We found that in
mammary epithelial cells, Cyclin D1 protein levels were
not changed in knock out mice as compared to wild type
(data not shown). However, the phosphorylation of AKT
was greatly increased in Ebp1-/- mammary tissue (Fig. 7A).
In prostate cancer cell lines, the expression of the andro-
gen receptor and the metastasis associated protein AGR2
Growth retardation of Ebp1-/- mice Figure 3
Growth retardation of Ebp1-/- mice. A. Photograph of wild type and Ebp1-/- male littermates at Day 30. B. Wild type, 
Ebp1+/- and Ebp1-/- littermates, derived from crosses of heterozygous parents, were weighed over a period of 60 days. Results 
are plotted as the mean body weight ± standard error of the mean. C. Wild type and Ebp1-/- male and female mice, the progeny 
of crosses of homozygous animals, were weighed at the days indicated. Two litters each were weighed KO = 9 mice, WT = 15. 
(*p = .013 at Day 10, p = .02 at day 18).
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has been demonstrated to be decreased by ectopic expres-
sion of Ebp1. We found that AGR2 mRNA (Fig. 7B, right
panel) and protein (Fig. 7B, middle panel) expression and
AR protein expression (Fig. 7B, right panel) were
increased in prostates of Ebp1 knock out mice as com-
pared to age matched controls.
Finally, based on data from MEFs, we examined serum
levels of IGF-1 from age matched wild type and knock out
mice by ELISA assays. IGF-1 was reduced to 66% of wild
type levels in serum of 6 month old mice (Fig. 8A). In
addition, Western blot analysis of adult liver and kidney
(3 month old mice) indicated that IGFBP-3 was reduced
in knock-out versus wild type organs (Fig. 8B).
Discussion
To characterize the physiological role of Ebp1, we gener-
ated Ebp1 deficient mice exhibiting a gene trap intro-
duced into intron 2 of the Ebp1 gene. The gene trap leads
to deletion of all but the first 20 amino acids of Ebp1
which have no biological function on their own. The most
striking feature of the Ebp1-/- phenotype was the small size
of the mice. It is of interest to note that inhibition of
expression of the potato homologue of Ebp1 also results
in a dwarf phenotype [4]. Ebp1-/- pups were on average
25% smaller than their wild type and heterozygous litter-
mates until Day 30, the approximate onset of puberty.
Mice were well proportioned with no skeletal abnormali-
ties other than a kinky tail in approximately 1/3 of the
mice. An unusual feature of our in vivo analysis is the fact
that the reduced weight was recovered after the prepubes-
cent stage, while Ebp1 is still normally transcribed and
Reduced cellular proliferation of MEFs from wild type and  Ebp1 knock out mice Figure 4
Reduced cellular proliferation of MEFs from wild 
type and Ebp1 knock out mice. A. MEFs were plated as 
described in the Materials and Methods and counted for 3 
consecutive days. B. Morphological appearance of Ebp1 
knock out (KO) and wild type (WT) MEFs after three pas-
sages.
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Table 1: Expression of proliferation associated genes on Ebp1 knock out versus wild type MEFs
Accession Number Gene Name Fold Change P
Insulin Family
BB787243 insulin-like growth factor binding protein 4 -2 .0014
BG075165 insulin-like growth factor -2 .0002
AV175389 insulin-like growth factor binding protein 3 -2.3 .0002
MAPK Signaling
NM_016719 Grb14 +1.9 .0002
NM_009231 Son of sevenless homolog 1 +5.1 .0007
X58876.1 mdm2 protein +2.5 .0004
AF022072 Grb-10 +2.2 .003
Cyclin Family
NM_007631 cyclin D1 +2.1 .0007
NM_009877 cyclin-dependent kinase inhibitor 2A (Cdkn2a), +3.2 .0004
Growth Factors and Growth Factor Receptors
L07264 heparin-binding EGF-like growth +2.2 .0001
NM_007540 brain derived neurotrophic factor (BDNF) +3.0 .0002
AW537708 PDGF receptor, alpha polypeptide -3.2 .003BMC Cell Biology 2008, 9:69 http://www.biomedcentral.com/1471-2121/9/69
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translated and therefore likely to have a regulatory role.
Although we are unable to explain the mechanism under-
lying this recovery, we report this observation as a possi-
ble example of temporal restricted competence in growth
regulation of specific cell types by Ebp1. This phenotype
is similar to that observed for the OTX 1 gene, a home-
obox containing gene that in vitro activates transcription
of GH, FSH, and LH [28].
It is of interest that the phenotype of Ebp1 knock out ani-
mals also resembles that of the IMP1 knock out mice [29].
IMP1 belongs to a family of RNA binding proteins impli-
cated in mRNA localization, turnover, and translational
control. These mice also exhibit a dwarf phenotype with
reduced proliferation of knock out MEFs. In these mice,
growth retardation is related to a hypoplastic small intes-
tine. In contrast, Ebp1 mice exhibit a transient dwarfism
and their intestines are both grossly and histologically
normal at 10 weeks. However, we were unable to assess
intestinal anatomy and histology at earlier time points,
and it remains possible that abnormalities occur when the
weight differences are most marked. Ebp1 has also been
shown to be an RNA binding protein with a sigma- 70 like
motif. This motif has been identified as a new RNA bind-
ing domain unique to the superfamily of Imp4 or Brix
proteins that are required for ribosome biogenesis [30]. A
role for Ebp1 in ribosomal biogenesis is supported by
studies indicating its localization in the nucleolus, its
association with 5 S ribosomal RNA, and its complexing
with proteins such as B23 which are involved in ribosome
processing[19]. Whereas the significance of RNA binding
proteins in spatial and temporal control of gene expres-
sion during development is evident in invertebrate organ-
isms, the function of RNA binding proteins during
mammalian development is less clear. With the exception
of FMRP, Dazla, and Nova-1, which are associated with
mental retardation, azospermia, and neuronal viability
respectively [31-33], the majority of the mammalian RNA
binding proteins are constitutively expressed and exhibit
a relative broad RNA-binding specificity. Further work is
needed to uncover the role that Ebp1's RNA binding activ-
ity has in the development of this phenotype and the tar-
get RNAs that specifically interact with Ebp1.
The molecular pathways leading to dwarfism are likely to
involve several mechanisms. As reduced growth was man-
ifested in the MEFs from Day 12.5 embryos, we used these
cells to measure changes in gene expression associated
with loss of Ebp1. Global gene expression analysis indi-
cated that expression of IGF-1 and the IGF binding pro-
teins IGFBP3 and 4 was decreased. The in vivo growth
promoting role of the IGFs has been demonstrated con-
clusively from the dwarfing phenotypes observed after tar-
geted mutagenesis of the mouse Igf1 and Igf1r genes. [34].
IGF-1 functions both during embryonic and post natal
development. IGF-1 mutants exhibit a birth weight that is
60% of normal and the difference between their size and
that of wild type mice increases progressively with age
[35]. The Ebp1 phenotype is not as severe as that observed
in IGF-1 deficient mice. The function of IGFBPs in cell
growth is more complex. However, one role is to sequester
and stabilize IGF-1 [36]. Thus, decreases in IGFBPs may
result in destabilization of IGF-1 and may be partially
responsible for lower levels of serum IGF-1.
We found that MAPK was constitutively phosphorylated
in MEFs derived from knock out mice. This constitutive
phosphorylation was associated with the overexpression
of SOS-1, an upstream activator of the Ras -MAPK signal
transduction pathway. It is possible that overexpression of
SOS-1 led to increased basal phosphorylation of MAPK.
In contrast, both the basal and HRG-induced activation of
the MAPK pathway is increased in EBP1 transfected breast
cancer cell lines [11]. The reasons for these apparently dis-
cordant findings may be related to the ligand used, the dif-
Validation of differential Cyclin D1 expression in wild type  and Ebp1 knock out MEFs Figure 5
Validation of differential Cyclin D1 expression in wild 
type and Ebp1 knock out MEFs. A. Conventional PCR 
analysis of Cyclin D1 and actin mRNA in wild type and knock 
out MEFs. B. Real Time quantitative RT-PCR analysis of Cyc-
lin D1 mRNA. The relative level of Cyclin D1 was normalized 
to β actin. Results are representative of 2 experiments using 
different sets of cells. C. Expression of Cyclin D1 protein in 
wild type and knock out MEFs. Lysates of Ebp1 knock out or 
wild type MEFs were resolved by SDS-PAGE and analyzed by 
western blotting with the indicated antibodies.
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ferential expression of ErbB receptors in breast cancer cells
versus fibroblasts, and the cellular background.
We have previously shown that inhibition of Ebp1 expres-
sion results in increases in phospho AKT in human breast
cancer cell lines, whereas ectopic expression of ebp1 inhib-
its HRG induced AKT activation [15]. Here, we found that
Ebp1 had no effect on AKT phosphorylation after EGF
stimulation of MEFs. However, AKT was constitutively
phosphorylated in mammary epithelial cells of knock-out
mice. The mechanism of the increase in AKT phosphoryla-
tion is unclear. Paradoxically, Ahn et al [16] have shown
the binding of Ebp1 to nuclear AKT increases AKT phos-
phorylation [37] in PC-12 neuronal cells. It is not known
if Ebp1 binds AKT in normal mammary epithelial cells or
affects its phosphorylation. These studies point up the
importance of tissue context in the activation of specific
signaling molecules. As activation of AKT is important in
development of mammary adenocarcinoma [38], we are
currently monitoring breast tumor incidence with age in
Ebp1 knock out mice. We have not yet seen increased
tumor incidence in a small cohort of mice that have been
carried until one year.
Finally, our laboratory has demonstrated that ectopic
expression of Ebp1 results in decreased expression of AR
and AR target genes and inhibition of growth of prostate
cancer cells both in vivo and in vitro [14]. In the current
study, deletion of the Ebp1 gene led to increased expres-
sion of AR in prostates of adult mice and upregulation of
the metastasis associated gene AGR2. AR plays a key role
in the development and progression of prostate cancer,
and we anticipate that the Ebp1  knockout mouse may
have a hyperactivated AR signaling axis that may result in
increased incidence of prostate cancer. Also with regard to
prostate cancer, decreased expression of IGFBP-3 is corre-
lated with increased risk of developing prostate can-
cer[39]. Western blot analysis verified that Ebp1 knockout
led to reduced protein levels of IGFBP-3 in liver and kid-
ney. We were unable to detect IGFBP-3 in prostates of
either wild type or knock out mice, but studies are ongo-
ing to assess if there are changes in IGFBP-3 expression in
Activation of kinase cascades in Ebp1 wild type and knock out MEFs Figure 6
Activation of kinase cascades in Ebp1 wild type and knock out MEFs. A. The expression of SOS-1 in logarithmically 
growing wild type and knock out MEFs was measured by Western blot analysis for SOS-1 and actin as indicated. B. WT and 
KO MEFs were serum starved for 24 hours and then stimulated with EGF (20 ng/mL) for the indicated times. Cells were lysed 
and Western blot analysis performed to examine the activation states of MAPK (B) and AKT (C) using phospho specific anti-
bodies directed against each protein. The expression of total MAPK and AKT was also measured as indicated. MAPK blots 
were analyzed by densitometry using Image-J software. Results presented in Panel B underneath each lane are the ratios of 
pixel densities of the pMAPK to MAPK bands.
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the prostates of knock out mice. We are also monitoring
the incidence of prostate cancer of the Ebp1-/- mice as they
age. Nevertheless, current studies, together with our previ-
ous reports, strongly suggest that Ebp1, as an endogenous
regulator of ErbB-AR crosstalk, may regulate expression of
a series of genes that are involved in aggressive prostate
cancer growth.
Conclusion
In summary, although Ebp1 appears to be dispensable for
prenatal development, loss of Ebp1 affects post-natal
growth. This growth delay may be related to changes in
IGF-1 and IGFBP levels and to changes in key components
of cellular proliferation pathways. Of interest, two genes
involved in prostate cancer progression, androgen recep-
tor and AGR2, are increased in prostates of Ebp1 knock
out mice. Our Ebp1-/- mouse line represents a new in vivo
model to investigate Ebp1 function in the entire organ-
ism.
Methods
Gene trap insertion in ES cells and generation of Ebp1-/- 
mice
Embryonic stem (ES) cells (129/SvEvBrd) with a retrovi-
ral gene trap vector insert (VICTR20) into the Ebp1 locus
(Omnibank no. OST 186047) were generated as
described previously [23] (Lexicon Genetics, Woodlands
TX). The location of the gene trap insertion was deter-
mined by sequence analysis. The Ebp1 targeted ES cells
were microinjected into C57BL/6 albino blastocysts, fol-
lowed by transfer to a foster mother (C57Bl/6) to gener-
ate chimeric animals. Chimeric males were mated with
C57Bl/6 albino females, and F1 agouti pups were ana-
lyzed for the presence of the transgene by PCR analysis
Changes in expression of Ebp1 target genes in adult tissue Figure 7
Changes in expression of Ebp1 target genes in adult tissue. A. Number 4 mammary glands were isolated from 10 week 
old wild type (WT) or Ebp1 knock out (KO) mice. Immunohistochemical analysis was performed for phospho AKT (p-AKT) or 
total AKT (T-AKT) as indicated. B. Expression of AR and AR regulated genes in prostates. The expression of AGR2 in the 
anterior prostates of age matched wild type and Ebp1 knock out mice were measured by real-time PCR (left panel) or West-
ern blot (middle panel) analysis. AR levels were measured in lysates of anterior prostates by Western blot analysis (Right 
panel).
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of 100 ng of tail genomic DNA with the following prim-
ers to detect mutant and wild type Ebp1 : For the mutant
gene primers directed against viral LTR2 (For-
ward):AAATGGCGTTAAGCTAGCTTGC: and Reverse
5'CCTTTAATCCCAG CACTCTGGAACG3'. For wild type
Ebp1 Forward PCR5'T AGAGCCTCTACAGTGTTTTGA
GG3' and Reverse 5'CCT TTAATCCCAGCACTCTGGA
ACG3'. For approximate positions of primers see Fig 1.
PCR amplification of wild type Ebp1 sequences leads to
a 308 bp product. Amplification of LTR2 and Ebp1 lower
leads to amplification of a 253 bp product to detect the
insert LTR2. Heterozygous Ebp1+/- mice were crossed to
obtain homozygous Ebp1-/- mice. The strain was main-
tained on a 50% C57BL/6–50% 129SvEvBrd back-
ground. The mice were bred on a 10 hour light:14 hour
dark cycle and had free access to drinking water and
standard chow. All mice were generated and maintained
in accordance with institutional guidelines approved by
the University of Maryland Baltimore Animal Care and
Use Committee.
Isolation of Mouse Embryo Fibroblasts (MEFS) and 
proliferation assays
Embryos (12.5 days)were minced and incubated in 0.25%
trypsin and 5 U of DNAse I for 37°C for 30 min. Dul-
becco's MEM supplemented with 10% fetal bovine serum
and penicillin and streptomycin were added to the cell
suspension and cells centrifuged at 1000 rpm for 10 min.
The pellet was resuspended in medium and cells were
grown in MEM and passaged by trypsinization. Cell pro-
liferation was measured by plating MEFs from each geno-
type at a density of 2 × 104 cells per 35 mm dish. Viable
cells were counted by Trypan blue exclusion using a
hemocytometer. Cells were used in passage 2 and 3. For
EGF stimulation experiments, passage 2 MEFs were plated
in 6 well plates in complete media. Cells were serum-
starved overnight and then stimulated for the indicated
times with EGF (Sigma, St. Louis, MO) at 20 ng/ml.
Microarray Analysis
First and second strand cDNA were synthesized from 5–
15 μg of total RNA at Genome Explorations (Nashville,
TN) using the SuperScript Double-Stranded cDNA Syn-
thesis Kit (Gibco Life Technologies) and an oligo-dT24-T7
(5'-GGC CAG TGA ATT GTA ATA CGA CTC ACT ATA
GGG AGG CGG-3') primer according to the manufac-
turer's instructions. cRNA was synthesized labeled with
biotinylated UTP and CTP by in vitro transcription using
the T7 promoter coupled double stranded cDNA as tem-
plate and the T7 RNA Transcript Labeling Kit (ENZO
Diagnostics Inc.). The fragmented cRNA was hybridized
to U133A oligonucleotide arrays (Affymetrix) containing
~33,000 full length annotated genes together with addi-
tional probe sets designed to represent EST sequences. The
arrays were then stained with phycoerythrein conjugated
streptavidin (Molecular Probes) and the fluorescence
intensities were determined using a laser confocal scanner
(Hewlett-Packard). The scanned images were analyzed
using Microarray software (Affymetrix). Sample loading
and variations in staining were standardized by scaling
the average of the fluorescent intensities of all genes on an
array to constant target intensity for all arrays used. The
signal intensity for each gene was calculated as the average
intensity difference, represented by [E(PM - MM)/
(number of probe pairs)], where PM and MM denote per-
fect-match and mismatch probes. Data Analysis was con-
ducted using Microarray Suite 5.0 (Affymetrix) following
user guidelines. Only genes with a mimmum expression
level of 500 were included in this analysis. Genes whose
expression varied more than two fold with a p value of <
0.05 were considered to be significantly different between
the two cell lines.
Real Time Quantitative Reverse-Transcription and 
Conventional PCR Analysis
The method of Nakanishi et al [40]was used as previously
described. Real-time quantitative RT-PCR was performed
Alterations of insulin signaling pathways in adult Ebp1 knock  out mice Figure 8
Alterations of insulin signaling pathways in adult 
Ebp1 knock out mice. A. Serum IGF-1 as measured by 
ELISA. IGF-1 levels in serum from Ebp1 knock out and wild 
type mice were assessed by ELISA as described in the Materi-
als and Methods. B. Liver and kidneys of 3 month old wild 
type (WT) and knock out (KO) mice were analyzed by 
Western blotting for expression of IGFBP-3 or actin as indi-
cated. Blots were analyzed by densitometry using Image-J 
software. Results presented underneath each lane are the 
ratios of pixel densities of IGFBP-3 to actin bands.
WT              KO
Liver
Kidney
WT         KO
IGFBP-3
Actin
IGFBP-3
Actin
I
G
F
-
1
 
[
n
g
/
m
l
]
0
200
400
600
800
1000
KO                 WT
A
B
1.61             1.23
1.17                .74
Ratio of IGFBP-3: Actin
Ratio of IGFBP-3 :ActinBMC Cell Biology 2008, 9:69 http://www.biomedcentral.com/1471-2121/9/69
Page 11 of 12
(page number not for citation purposes)
on the LightCycler (Roche) platform to determine relative
mRNA levels of genes under study. The following forward
and reverse primers were selected using Primer Express
software and synthesized by the Core Laboratory of Uni-
versity of Maryland School of Medicine: Ebp1, sense: 5'-
GCACGCCAATAGAAGG-3'and antisense: 5'-GTAAACG-
GCATGGCATC-3', β-Actin, sense: 5' GCT ATC CAG GCT
GTG CTA TC-3' and antisense TGT CAC GCA CGA TTT
CC-3', Cyclin D1, sense 5'-GCAGCACCCGGTCGTT-
GAGGA-3' and antisense:5'-TCCGGAGACCGGCAGT-
ACA-3', AGR2, sense: 5' ATTGGCAGAGCAGTTTGTCC
and antisense: 5'GAGCTGTATCTGCAGGTTCGT[41]. A
SYBR Green PCR Kit was used (Applied Biosystems, Foster
City, CA) and the analyses were performed in duplicate or
triplicate in a total volume of 15 μl including 0.9 μl of 25
mM MgCl2, 1.5 μl SYBR Green I, 0.3 μl Enzyme Mix, 0.75
μl of each primer (50 ng/μl) and 2 μl of cDNA synthesized
with random hexamers. Target mRNA values were nor-
malized using β-actin mRNA as an internal control. The
relative quantitation of gene expression was performed
using the comparative ΔΔCt (threshold method) using β-
actin as an internal control [42].
Conventional PCR analysis was performed as previously
described [2]. PCR products were visualized on 1.2% aga-
rose gels stained with ethidium bromide.
Western Blot Analysis
Briefly, total cell extracts were prepared by direct lysis of
cells with buffer containing 50 mM Tris-HCl (pH 7.4), 1
mM EDTA, 250 mM NaCl, 1% Triton X-100, 0.5 mM DTT
and 1 mM PMSF. Proteins concentrations were measured
using a detergent compatible kit (BioRad, Hercules, CA).
Proteins were resolved by SDS-PAGE and analyzed by
Western blotting as described [6]. The Ebp1 antibody was
from Upstate (Lake Placid, NY), Cyclin D1, IGFBP-3, SOS-
1 and Androgen Receptor antibodies from Santa Cruz
(Santa Cruz, CA), the phospho AKT and AKT antibodies
from Cell Signaling (Beverly, MA), the phospho MAPK
and MAPK from Promega (Madison, WI), the AGR2 anti-
body from Dr. Charles Young, Mayo Clinic[43], and the
polyclonal antibody to actin from Sigma (St. Louis, MO).
Images were quantified using IMAGE-J software (NIH).
Measurement of IGF-1 levels
IGF-1 levels in serum and conditioned media were deter-
mined using an IGF-1 ELISA kit from R&D Systems (Mpls,
MN) as directed by the manufacturer. For conditioned
media preparation, passage 2 MEFs were plated at a den-
sity of 2 × 104 cells per 35 mm dish in 3 ml of complete
media. Media were collected 3 days later.
Immunohistochemical staining
Mammary glands (#4) were excised and fixed in 10%
buffered neutral formalin. Sections of formalin-fixed, par-
affin-embedded tissues were cut to 5 μm. Slides were
stained with Cyclin D1, phospho AKT and total AKT anti-
bodies [43]diluted 1:100 using the standard avidin-biotin
method (Vecta-Stain Kit, Vector Labs, Burlinghame, CA)
with Harris hematoxylin as a counterstain.
Statistical Analysis
Data were analyzed using a two-tailed Students t-test and
a p < 0.05 was deemed statistically significant.
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